Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Inari Medical

Explore full profile

Medical device company developing devices for the interventional treatment of cardiovascular diseases

Aliso Viejo, United StatesFounded 2011Biotech & Life Sciences
Valuation $2.5–5B Latest valuation · 2025
Revenue $500M–1B Latest reported FY
EBITDA $15M Latest reported FY
Headcount 500–1k Current team size
Total funding $10–50M Disclosed equity funding

About Inari Medical

In 2011, Inari Medical was founded in Irvine, California, by Bob Rosenbluth, Brian Cox, and Paul Lubock. The company emerged from the medical device incubator Inceptus Medical, with a mission to innovate in the treatment of venous thromboembolism (VTE) and other vascular conditions.

Read full description

Inari Medical developed mechanical thrombectomy devices designed to remove blood clots from veins, offering a minimally invasive alternative to traditional treatments. This innovation aimed to improve patient outcomes and reduce recovery times, addressing a significant need in the medical community.

The company gained momentum with a significant Series C funding round of $27 million, led by Gilde Healthcare, which enabled further development and commercialization of their products. This financial boost was crucial in expanding their market presence and accelerating product innovation.

Inari Medical's journey reached a pivotal moment in May 2020 when the company went public on the NASDAQ under the ticker symbol NARI. The IPO marked a significant milestone, reflecting the company's growth and its potential in the medical device industry.

Today, Inari Medical continues to focus on advancing its technologies and expanding its reach in the healthcare sector, driven by a commitment to improving patient care and outcomes through innovative solutions.

Source: Dealroom company data

At a glance

Founded
2011
Headquarters
Aliso Viejo, United States
Listing
IPO 2020
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Inari Medical.

See all news

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later1 investor entered at this stage

  • Gilde Healthcare
Employees mapped 642 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 33 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
24 countries with
team presence
🇺🇸 United States86.4%
🇩🇪 Germany3.5%
🇫🇷 France1.4%
🇦🇺 Australia1.1%
🇨🇷 Costa Rica0.9%
Top 5 of 24 shown
Web traffic by country
11K monthly visits
across markets
🇺🇸 United States42.7%
🇨🇦 Canada18.2%
🇬🇧 United Kingdom11.8%
🇯🇵 Japan8.2%
🇮🇳 India7.3%
Top 5 markets shown

Patents

Estimated portfolio value
$81M

66 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Inari Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Inari Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.